Last updated: 25 days ago
AstraZeneca's $50 Billion Investment: Boosting US Manufacturing & R&D by 2030
AstraZeneca plans to invest $50B in US manufacturing and R&D by 2030, aiming for $80B revenue. This will create tens of thousands of jobs and enhance drug production capabilities.